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OPTIMAL RECOVERY OF SSEA-41/OCT-41/CD1331/CXCR41/LIN-/
CD45- VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS FROM
UMBILICAL CORD BLOOD (CB) USING PLASMA DEPLETION/REDUCTION
(PDR) COMPARED TO RED CELL REDUCTION (RCR)
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We previously reported the presence of VSEL stem cells (SC) in
CB which are capable of tri-lineage differentiation, and the tech-
niques to identify and isolate these cells (Leukemia 2007;21:297-
303). Because of their small size (\ 6 mm) and different cell density,
42.5612.6% of these VSEL SC in CB are lost upon red cell reduc-
tion (RCR) processing with AXP AutoXpress technology, and
significant percentages of VSEL SC are also lost with Ficoll-Paque
and red cell lysis techniques (Europ. J. Hematology 2009;84:34-
46). Moreover, after thawing, 82.7617.3% of the VSELs cyopre-
served after RCR are recovered. Since these CB VSELs may be
important for regenerative medicine applications and contribute
to CB hematopoiesis and possess potential of long term repopulat-
ing hematopoietic stem cells (LT-HSCs), we sought to optimize
recovery of these cells with different CB volume reduction tech-
niques. Previously, it was reported that plasma depletion/reduction
(PDR) of CB loses less than 0.01% of nucleated cells in the
discarded plasma portion (Biol. Blood Marrow Transplant
2007;13:1346-57), so we performed 3 parallel comparisons using
CB products that were divided into two equal portions processed
using either hetastarch (HES) RCR or PDR. As can be seen in
the table below, there is essentially no loss of VSEL SCs that we
can detect after PDR processing, compared to 44.763.9% VSEL
SC loss with RCR. Post-thaw, the two types of products appear
to yield similar recoveries of VSELs compared to post-processing
and pre-freeze samples (85.2% PDR versus 86.8% RCR). We con-
clude that (1) we confirmed our previous observations of significant
CB VSEL SC loss with standard RCR techniques, this time using
a manual HES RCR method, (2) PDR offers essentially 100%
recovery of VSEL SCs in CB, and (3) even after thawing, PDR re-
tains 85.2% of the collected VSELs compared to 50.9% for HES
RCR. Whether these observations extend to the outstanding trans-
plant-related mortality (TRM), overall (OS) and disease free sur-
vival (DFS) seen with PDR CB transplants, and whether VSELs
are responsible for the effect seen with post-thaw wash versus direct
infusion on chronic GvHD, TRM, OS and DFS are the subjects of
current investigations.
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Introduction: Around 10 % and 1.7% of healthy related PB do-
nors in Japan responded poorly to G-CSF, from whom CD341
cells below 2x10E6 /kg and 1x10E6 /kg (donor’s body weight:
dBW) harvested respectively. From October 2010, Japan Marrow
Donor Program started transplantation using unrelated donor’s
PB graft. Poor mobilization of PB graft is disadvantageous for
both the donor and the patient to whom transplanted by the PB
graft. Therefore it is useful to predict the total yield of PB graft be-
fore or soon after G-CSF administration.
Donors and Methods: After informed consent was obtained, 10
mg/kg/day (dBW) of nartograstiom (Kyowa Hakko Kogyo Co., Ja-
pan) was subcutaneously injected once a day to 7 healthy sibling
donors for 5 days. The donors were 2 males and 5 females. The
median age was 36 years old, ranging from 21 to 56. PB graft
was harvested by CS-3000 plus (Fenwall, Deerfiild, IL, USA)
on both day 4 and day 5. Eight to 10 liters of donor PB were pro-
cessed in a day. The expressions of adhesion molecules (AM) in-
cluding of CD11a, CD11b, CD49d and CD62L on CD341 cells
in PB (day 1 and 3) or PB graft (day 4 and 5) were analyzed by
FACScan (Becton Dickenson, Moutain View, CA, USA). The
yield of PB graft (YPBG) is represented by the total number of har-
vested CD341 cells per dBW (kg) and processed blood volume
(lette:r : L).
Results: The median of YPBG was 6.11x10E5 /kg/L, ranging from
2.73x10E5 to 8.73x10E5 /kg/L. The medians of the mean fluores-
cence intensity (MFI) of AM on PB CD341 on day 1, 3, 4, 5 were
82.4, 69.1, 46.1, 34.4 for CD11a, 45.2, 33.8, 32.0, 36.6 for CD11b,
141, 78.7, 69.6, 66.9 for CD49d, 82.4, 69.1, 46.1, 34,1 for CD62L,
respectively. Table.1 indicates results of statistical analysis.The
MFI of CD11a, CD11b and CD49d on PB CD341 cells on each
day are significantly changed by subcutaneous injection (S.C.) of
G-CSF. The MFI of CD11a on PB CD341 cells within each donor
is significantly different with YPBG.TheMFI of CD11a andCD11b
on PB CD341 cells before S.C. of G-CSF significantly correlated
inversely with YPBG. On day 5, PB CD341 cells preserve the in-
verse correlation of the MFI of CD11b with YPBG, however these
lost the inverse correlation of the MFI of CD11a with YPBG. The
MFI of CD49d and CD62L expression on PB CD341 cells did
not correlated with YPBG.
Conclusion: These findings suggest the possibility of predicting
YPBG and the risk of poor mobilization.of Regression Lines in
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